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HSP90 chaperones are essential regulators of cellular function, as they ensure the appropriate
conformation of multiple key client proteins. Four HSP90 isoforms were identified in the proto-
zoan parasiteTheileria annulata. Partial characterization was undertaken for three and localization
confirmed for cytoplasmic (TA12105), endoplasmic reticulum (TA06470), and apicoplast
(TA10720) forms. ATPase activity and binding to the HSP90 inhibitor geldanamycin were demon-
strated for recombinant TA12105, and all three native forms could be isolated to varying extents
by binding to geldanamycin beads. Because it is essential, HSP90 is considered a potential
therapeutic drug target. Resistance to the only specific Theileriacidal drug is increasing, and one
challenge for design of drugs that target the parasite is to limit the effect on the host. An
in vitro cell culture system that allows comparison between uninfected bovine cells and the
T. annulata‐infected counterpart was utilized to test the effects of geldanamycin and the deriv-
ative 17‐AAG. T. annulata‐infected cells had greater tolerance to geldanamycin than uninfected
cells yet exhibited significantly more sensitivity to 17‐AAG. These findings suggest that parasite
HSP90 isoform(s) can alter the drug sensitivity of infected host cells and that members of the
Theileria HSP90 family are potential targets worthy of further investigation.1 | INTRODUCTION
Chaperone proteins are fundamental to the enablement of conforma-
tional changes in a wide range of cellular effector (client) proteins,
especially under conditions of stress (Morimoto, 1998; Kennedy, Jäger,
Mosser, & Samali, 2014). Conformational change can result in stabiliza-
tion, degradation, or activation of client proteins. HSP90 chaperones,
however, are particularly known for their tendency to interact with
specific proteins involved in essential cellular regulation under non‐
stress conditions: client proteins include nuclear hormone receptors,
kinases, and transcription factors (Pearl & Prodromou, 2006). HSP90s
are essential in eukaryotes, and because of their involvement in so
many cellular processes, including proliferation and metastasis, they
are the subject of extensive investigation as therapeutic targets for
many types of cancer.
Theileria annulata is a tick‐transmitted apicomplexan parasite of
bovids and is the causative agent of tropical theileriosis. This diseasee Creative Commons Attribution Li
ed by John Wiley & Sons Ltd.
wileyonlinelibrary.cois prevalent from Southern Europe to the Middle East extending into
the Far East. Infected cattle have a high mortality as a result of infec-
tion, and in cattle that recover a carrier state may develop resulting
in significant losses in productivity. Increasingly, the disease is being
identified in Mediterranean countries such as Italy, Spain, Portugal,
and Greece, possibly due to increased prevalence of the tick vector
as a result of global warming. T. annulata undergoes several stage
differentiation events during its life cycle that require adaptation to
different cellular environments: a sexual cycle occurs in the tick vector,
followed by generation of the sporozoite stage in the salivary glands;
invasion of the bovine leukocyte by the sporozoite, followed by differ-
entiation to a multinucleate intracellular macroschizont; a switch from
the macroschizont stage to production of uni‐nucleate merozoites;
invasion of erythrocytes and development into piroplasms, a life cycle
stage that may represent gametocytes that are transmitted to the tick
vector on feeding (reviewed in (Dobbelaere & Heussler, 1999)). Infec-
tion of the leukocyte is accompanied by modulation of the host cellcense, which permits use, distribution and reproduction in any medium, provided
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type upon establishment of the macroschizont (Baylis, Megson, & Hall,
1995; Baumgartner et al., 2000; Kinnaird et al., 2013). Host cell trans-
formation generates the capacity for unlimited division and develop-
ment of significant metastatic potential, both of which are associated
with the pathogenesis of acute disease. Given the known role of
HSP90 in carcinogenesis, host and/or parasite isoforms of HSP90
chaperones may be required for maintenance of the transformed phe-
notype of the infected leukocyte.
Studies on other closely related Apicomplexans, e.g., Plasmodium
falciparum, as well as the coccidians Toxoplasma gondii and Eimeria
tenella, have demonstrated a role for Hsp90 in progression of the life
cycle. For example, exposure to the specific Hsp90 inhibitor,
geldanamycin (GA) has been shown to disrupt the transition from rings
to trophozoites in P. falciparum (Banumathy, Singh, Pavithra, & Tatu,
2003); in Eimeria tenella, treatment of sporozoites with GA inhibited
invasion and development to the schizont (Péroval, Péry, & Labbé,
2006); and for Toxoplasma, GA can inhibit the switch from tachyzoite
to bradyzoite (Echeverria et al., 2005). Thus, HSP90 plays an important
role in enabling stage differentiation events in this parasite group.
One known substrate or client protein of HSP90 is a kinase (IKK)
involved in degradation of the inhibitor of the transcription factor
NF‐κB. Inhibitor degradation allows translocation of NF‐κB to the
nucleus leading to transcriptional activation of numerous target genes,
particularly those involved in the inflammatory response and protec-
tion against apoptosis. This process is known to occur in Theileria‐
infected cells (reviewed in (Dobbelaere & Kuenzi, 2004)) where IKK
signalosomes, involved in signal transduction of NF‐κB activation,
were identified on the surface of the macroschizont (Heussler et al.,
2002). However, unusually, no bovine HSP90 was detected within
these complexes (Hermann & Dobbelaere, 2006), raising the question
as to how functionally competent signalosomes are formed and
whether a divergent parasite derived isoform might be involved.
One form of HSP90, encoded by gene TA12105, was partially
characterized in the closely related parasite, Theileria parva, by
Gerhards et al. (Gerhards et al., 1994). Using a specific antibody gener-
ated against 88 aa at the C‐terminus, they demonstrated that it was
localized to the macroschizont cytoplasm, a location typical of the clas-
sical form of HSP90. In a more recent study (Mohammed, Bakheit,
Ernst, Ahmed, & Seitzer, 2013), the sequence properties of two other
HSP90 type proteins, TA06470 (115.6 kDa) and TA10720
(104.2 kDa), were briefly described but no putative function or loca-
tion was highlighted. The work presented here extends these prelimi-
nary analyses for three T. annulata HSPs (TA12105, TA06470, and
TA10720) and describes their subcellular localization within
macroschizont‐infected cells, binding affinities for GA and expression
across different life cycle stages.
A primary aim of this study was to address the potential role of
HSP90 isoforms in parasite dependent establishment and modulation
of infected host cell phenotype. Moreover, as instances of infections
resistant to the theileriacidal drug, buparvaquone, are increasingly
recorded in the field (Mhadhbi et al., 2010; Sharifiyazdi, Namazi,
Oryan, Shahriari, & Razavi, 2012; Mhadhbi et al., 2015), there is a
requirement for development of additional drugs targeted against the
parasite that have minimal impact on the host animal. The availabilityof a wide range of tailored HSP90 inhibitors, together with structural
divergence of the apicomplexan HSP90 isoforms from those of the
host, highlights their potential as drug targets. The results of this study
indicate that there is potential merit in this approach.2 | RESULTS
2.1 | The HSP90 isoforms encoded in the T. annulata
genome
The T. annulata genome sequence (http://www.genedb.org) was ana-
lyzed by BLAST for similarities to the mammalian HSP90 protein
sequence. Four HSP90‐like proteins were identified: TA12105, the
classical, cytoplasmic form of HSP90 (predicted molecular mass of
83.8 kDa), TA06470 (115.6 kDa), TA10720 (104.2 kDa), and
TA06845 (83.0 kDa) (summarized in Supplementary Table 1A). The
sequence of each of these isoforms was used to identify the most
closely related variants in the nearest (Babesia and Plasmodium) and
more distant (Toxoplasma and Cryptosporidium) genera by BLAST
searches of the apicomplexan database at NCBI. A selection was cho-
sen to determine their phylogenetic relationship, and this is presented
as a maximum likelihood tree (Figure 1). Four clusters are evident, and,
overall, the tree is very stable with good bootstrap support throughout.
Each of the four T. annulata isoforms appears in a different cluster,
each of which represents an orthologous group. This indicates that
four HSP90 variants existed in the common ancestor of the modern
apicomplexan genera represented in the analysis. As might be
expected, the Theileria/Babesia sequences cluster closely for each of
the HSP90 types. The B. equi sequence is sometimes slightly closer
to the Theileria species (n = 2) and sometimes closer to the other
Babesias (n = 2).
Further characterization of the Theileria member of each of these
orthologous groups was then undertaken, although, for TA06845, this
was limited to noting a predicted amino acid sequence similarity (63%)
to the mammalian mitochondrial chaperone, Trap, using T. annulata
GeneDB.
2.2 | TA12105
The TA12105 gene encodes a predicted protein of 721 amino acids
with a molecular mass of 83.8 kDa, possessing 66% identity and 81%
similarity to mammalian HSP90 alpha. This HSP90 isoform was first
identified by Gerhards et al. (Gerhards et al., 1994). TA12105 contains
a conserved C‐terminal MEEVD motif known to be involved in binding
of TPR domain containing co‐chaperones such as HOP (Chen, Sullivan,
Toft, & Smith, 1998). This motif is typical of all cytoplasmic forms of
HSP90 and is absolutely conserved in the other members of the
Apicomplexa examined (Figure 2a). As can be seen, the remainder of
the C‐terminus is reasonably well conserved across the different spe-
cies, and this is typical of the whole protein (Supplementary Figure 2).
2.3 | TA10720
Theileria annulataHSPs, TA10720 and TA06470 described below, have
not been previously characterized, apart from preliminary sequence
FIGURE 1 Maximum likelihood tree grouping Theileria, Babesia, and Plasmodium HSP90 variants. Accession numbers for the species used in this
analysis are given in Supplementary Table 1B: Species prefixes are Tp, T. parva; To, T. orientalis; Pf, P. falciparum; BBov, B. bovis; BBig, B.
bigemina; Beq, B. equi; PVX, P. vivax; PCHAS, P. chabaudi; TG, T. gondii; and Cp, C. parvum. The suffix HSP_1 represents the group containing
TA12105. HSP90_2 represents the group containing TA10720. HSP90_3 represents the group containing TA06470. HSP90_4 represents the
group containing TA06845
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TA10720 gene predicts a protein of 104.2 kDa and 913 aa, somewhat
larger than the cytoplasmic form of HSP90 described above. A poten-
tial signal peptide is present at the N‐terminus with an overlapping
transmembrane domain, and the protein is predicted to be targeted
to the apicoplast. An apicoplast targeting sequence is not well defined,
but it has been studied in P. falciparum (Foth et al., 2003) where it is
rich in K and N residues downstream of a signal peptide, as are the
Theileria orthologues (Figure 2b). The putative P. falciparum orthologue
(927 aa) which groups as expected in the phylogenetic tree (Figure 1) is
a similar size to the predicted T. annulata protein (913 aa). However,
the B. bovis and B. bigemia orthologues are significantly smaller (795
and 798 aa) (Supplementary Figure 3). Only five of the selected
sequences that map to this orthologue group (as shown in the align-
ment) met the criteria of Foth et al. (Foth et al., 2003) for either a signal
peptide or an apicoplast targeting sequence predicted by the
PlasmoAP tool at PlasmoDB. However by SignalP3.0 analysis, all puta-
tive orthologues contain an N‐terminal signal peptide necessary for
transport. Further analysis using recently developed software,
ApicoAP (Cilingir, Broschat, & Lau, 2012), designed to address the dif-
ficulties in reliably identifying apicoplast targets sequences from
Apicomplexans other than Plasmodium sp, predicted all the group 2
orthologues analyzed to have an apicoplast targeting sequence within
the 80 aa downstream of the signal peptide. This is based on the iden-
tification of a region downstream of a signal peptide which is depleted
for acidic (D,E) but enriched in polar, hydrophilic, or basic residues (H,K,R,N,Q,S,P,Y). Notably, the B. bovis orthologue described here was iden-
tified as likely to be targeted to the apicoplast in the analysis that
tested the prediction software (Cilingir et al., 2012). Although our anal-
yses (Figures 1 and 2B and Supplementary Figure 3) clearly indicate
the relationship between members within group 2 and predict their
localization to the apicoplast, the multiple alignment over the first 80
or so amino acids is the region that shows least similarity for Babesia
sp with the Theileria and Plasmodium orthologues (Supplementary
Figure 3): thus, the Babesia sp. are not shown in the short alignment
presented in Figure 2b. It is likely that there is considerable diver-
gence in the apicoplast targeting sequence and possibly also in the
mechanism of translocation within the Apicomplexa.2.4 | TA06470
The gene TA06470 encodes an HSP90‐related protein of 115.6 kDa
and 988 aa. As in TA10720, there is a predicted signal peptide, but in
addition, there is a conserved endoplasmic retention sequence at the
C‐terminus (Chang, Erwin, & Lee,, 1989) (Figure 2c), suggesting it func-
tions as an ER chaperone in a similar fashion to mammalian GRP94.
Generally, over the whole protein, there is good conservation (Supple-
mentary Figure 4) within the Apicomplexa. The closest orthologues
amongst the Apicomplexa found by BLAST searching are the predicted
endoplasmins (average MW 94 kDa) from Plasmodium spp. and the
Babesia HSP90s (Supplementary Table 1B). Two B. orientalis HSP90s,
including an orthologue of TA06470, were recently the subject of a
FIGURE 2 Protein sequence alignment of the defining features of each of the apicomplexan HSP90 isoforms indicating the overall similarity and
motif relationship between the orthologues; Ta, Theileria annulata; Tp, Theileria parva; To, Theileria orientalis; Pf, Plasmodium falciparum; PVX,
Plasmodium vivax; PCHAS, Plasmodium chaubaudi; Bbov, Babesia bovis; Bbig, Babesia bigemina. a. Comparison of C‐termini sequences from HSP90‐
like proteins in group 1 (cytoplasmic isoform) across Theileria, Babesia, and Plasmodium species indicating conservation of the motif, MEEVD,
characteristic of cytoplasmic forms of HSP90. b. Comparison of N‐terminal sequences from putative apicoplast HSP90 proteins (Group 2) from
Theileria and Plasmodium species. The apicoplast targeting sequence is rich in K and N downstream of predicted signal peptide (red). Babesia sp.
while predicted to be targeted to the apicoplast is not included in the alignment due to the level of divergence (Supplementary Figure 2). c.
Comparison of C‐termini sequences from HSP90‐like proteins in group 3 (endoplasmic reticulum isoform) acrossTheileria, Babesia, and Plasmodium
species indicating conservation of an endoplasmic reticulum retention signal sequence. Accession numbers are given in Supplementary Table 1B
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Alignment of the selection of Apicomplexan HSP90s within this group
(Supplementary Figure 4) indicates variably positioned insertions
downstream of the ATP binding domain suggesting divergent
functions and/or different client proteins.2.5 | Expression profiles across T. annulata life cycle
stages
Expression profiles of the three Theileria HSP90 genes (TA12015,
TA10720, and TA06470) across the different life cycle stages associ-
ated with bovine infection were generated from a published T. annulata
microarray dataset (Pieszko, Weir, Goodhead, Kinnaird, & Shiels, 2015)
that represents expression levels for each parasite gene in the genome
at the sporozoite, macroschizont, merozoite, and piroplasm stage.
There was no significant difference in RNA expression levels among
the stages, indicating that these genes are likely to be constitutively
expressed throughout the life cycle (Supplementary Figure 5). In addi-
tion, no significant increase in expression was observed when
merogony was induced by culture at 41°C, with time points examined
representing the intermediate phase (Day 4) and Days 7 and 9 where
merogonywas shown to occur. However by immunoblot analysis, com-
pared to the level of constitutively expressed β‐tubulin, a small increase(<2‐fold) in levels of cytosolic TA12105 protein was observed in
Theileria‐infected cells following a short (2 hr) heat shock at 42°C indi-
cating that expression of TA12105 may be influenced by a stress
response. A small reduction was observed after a recovery period at
37°C, suggesting that TA12105 is relatively stable with a slow
turnover rate (data not shown).2.6 | T. annulata HSP90 proteins show different
cellular localizations
The specific antibodies to TA12105, TA10720, and TA06470 were
used to determine the localization of each of the three T. annulata
HSP90 proteins within the macroschizont by immunofluorescence
(IFAT) and subcellular fractionation. IFAT using an anti‐peptide anti-
body confirmed the predicted cytoplasmic localization of TA12015 in
TBL20 and cloned cell line, D7, where the parental line derived from
an infected animal (Figure 3). Some concentration of the antigen
around the macroschizont nuclei was also observed. No other cellular
localization was detected. When infected cells were fractionated into
four different cellular compartments, a polypeptide of 83 kDa was
detected predominantly in Fraction I, the cytoplasmic fraction
(Figure 4A) with only a small amount in Fraction II, which is enriched
for membranes and organelles. As TA12105 appears to be quite highly
FIGURE 4 Comparative Western blot analysis of antibody reactivity
to Theileria HSP90 variants and bovine host GRP94 in subcellular
KINNAIRD ET AL. 5 of 13expressed, this most likely represents carry over during fractionation
or alternatively, a proportion may be associated with internal
membranes.
Reactivity against a polypeptide of 83 kDa in the piroplasm stagewas
not detected by immunoblot (data not shown); rather, three predominant
reactive polypeptides of 75, 50, and 45 kDa were observed. Similarly,
Gerhards et al. (Gerhards et al., 1994) did not detect any reactivity in piro-
plasms using an antibody generated against 663 aa at the C‐terminus,
although an RNA species of the correct size was present, in agreement
with our microarray expression data for this gene. The results indicate
expression of the gene as a polypeptide that subsequently undergoes
cleavage in the piroplasm stage or during production of the piroplasmpro-
tein extract. An antiserumdirected against a different piroplasm protein, a
30–32 kDa surface antigen (Glascodine et al., 1990), showed it to be
intact and of the correct molecular mass, indicating protein cleavage/deg-
radation is not a general phenomenon (data not shown). Using the antise-
rum against TA12105, no reactivity was observed with the uninfected
control cell line BL20, either by IFAT or Western blot, demonstrating
specificity for infected cells (Figures 3 and 4A).
fractions prepared from BL20 (uninfected) and TBL20 (Theileria‐
infected) cells. Extracts were prepared using the S‐PEK cell
fractionation kit (Pierce). Fraction I, enriched for cytoplasmic proteins;
Fraction II, enriched in membranes and organelles; Fraction III,
enriched for nuclei; and Fraction IV, residual insoluble proteins
including intermediate filaments2.7 | TA10720
For TA10720, the polyclonal antibody generated against the C‐
terminus recognized several clear punctate structures within theFIGURE 3 Comparative reactivity by
immunofluorescence of anti‐sera to parasite
HSP90 isoforms and to bovine GRP94. BL20 is
an uninfected bovine cell line used as a
control, TBL20 is BL20 infected with
T. annulata and D7, an in vivo derived cloned
T. annulata infected cell line. Host and parasite
nuclei were co‐stained with DAPI (blue) and
primary antibody reactivity detected with
Alexa 488 (green). TA12105, anti‐peptide
anti‐serum to TA12105, the cytoplasmic form
of HSP90; TA10720, anti‐serum to TA10720,
the apicoplast form of HSP90; TA06470,
anti‐serum to TA06470, the endoplasmic
reticulum HSP90; BtGRP94, a commercial
anti‐serum against mammalian GRP94, which
resides in the lumen of the ER; TA06470/
TaSP, T. annulata TaC12 cells co‐stained with
anti‐TA06470 and anti‐TaSP which reacts
with the macroschizont membrane (red). Bar is
10 μm
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bodies (Figure 3), supporting the predicted location. By Western
analysis, the predominant polypeptide of ~110 kDa matches the
predicted size of 104 kDa for TA10720 (Figure 4B) and was
detected predominantly in Fraction II, which is enriched for mem-
brane and organelles. A small amount is detectable in cytoplasmic
Fraction I. No reactivity was detected against the uninfected con-
trol cell line BL20.2.8 | TA06470
The polyclonal antibody generated to the C‐terminus of TA06470
predominantly recognized an extensive network of membranous‐like
strands linking multiple, bright, punctate bodies within the
macroschizont of TBL20 and D7 cell lines (Figure 3). By Western
analysis of subcellular fractions, a polypeptide of ~120–130 kDa
(the predicted MW for TA06470) was detected that is specific to
infected cells (Figure 4C). In these studies, TA06470 partitioned
predominantly with membranes and organelles (Fraction II) in
TBL20 (Figure 4C), but a significant amount was also observed in
the cytoplasmic fraction. In the D7 cloned cell line, TA06470 was
also associated with the cytoplasmic fraction and smaller amounts
in nuclear (Fraction III) and the Fraction (IV) containing residual insol-
uble material such as intermediate filaments of the cytoskeleton.
When the same extracts were probed with a commercial antibody
to mammalian GRP94, an HSP90 typically found in the lumen of
the endoplasmic reticulum, no signal was detected in the cytoplasmic
fractions of either BL20 or TBL20 (Figure 4D). The observation that
TA06470 is detected in other cellular compartments by Western blot
could indicate a low level of secretion into the host compartment,
but no clear evidence for this was found by IFAT on co‐staining with
an antibody that demarcates the surface of the macroschizont (anti‐
TaSP, Figure 3).2.9 | GRP94
In common with recent observations for other HSPs (reviewed in
(Tsutsumi & Neckers, 2007; Wong & Jay, 2016)), mammalian GRP94
(also known as GP96), which is typically present in the ER, has been
shown to exist in minor quantities on the cell surface of transformed
cells but not normal cells (Altmeyer et al., 1996). IFAT usinganti‐GRP94 detected a close association with the cell surface/
periphery in TBL20, and this pattern was particularly evident in the
infected D7 cell line (Figure 3). In addition, GRP94 appears to be signif-
icantly more abundant in the two T. annulata infected cell lines com-
pared to uninfected BL20 cells. This observation was supported by
examination of a previously published microarray data set that com-
pares host gene expression in BL20 and TBL20 cells (Kinnaird et al.,
2013). The data indicated that the bovine GRP94 gene exhibited
statistically significant (FDR 0.02) elevation in expression (>1.4‐fold
absolute) in TBL20 compared to BL20 and that this increased expres-
sion was reversible when TBL20 cells were exposed to the anti‐
parasite drug, buparvaquone.2.10 | Native HSP90 isoforms from T. annulata‐
infected cells show variable binding to geldanamycin
The abilities of different HSP90s present in detergent extracts of
Theileria‐infected cells to bind to the HSP90 inhibitor, geldanamycin
(GA), were assessed by capture on GA magnetic beads followed by
detection of eluted protein with the specific HSP90 antibodies. Both
mammalian and T. annulata (TA12105) cytoplasmic forms of HSP90
were clearly detected in the eluate from GA‐beads indicating that
TA12015 also had significant affinity for GA. Estimates of the ratio
of total protein reactivity relative to that of eluted protein by densi-
tometry generated a lower ratio for TA12015 (1.5 versus 2.2 for
host, Figure 5). Interestingly, both TA10720 (apicoplast) and
TA06470 (parasite ER) could bind to a limited degree, as low
reactivities were detected in the eluate. Virtually, no host GRP94
was detected in the eluate indicating very limited binding to GA‐
beads (Figure 5).2.11 | Recombinant TA12105 has ATPase activity
To investigate the properties of the cytoplasmic form of T. annulata
HSP90, TA12105, compared to those of the bovine orthologue,
full‐length recombinant TA12105 was expressed in E. coli as a histi-
dine‐tagged fusion protein and affinity purified (Figure 6a). As in our
previous experiments using native protein, the purified fusion pro-
tein reacted strongly with the specific peptide antiserum to
TA12105 while an antibody specific for bovine HSP90 showed no
cross‐reactivity with the recombinant protein by immunoblotFIGURE 5 Detection of the geldanamycin
binding affinities of HSP90 variants present in
detergent extracts of T. annulata infected cells
using biotinylated geldanamycin immobilized
on streptavidinmagnetic beads: Bovine HSP90
(HSP90); T. annulata cytoplasmic HSP90
(TA12105); T. annulata apicoplast HSP90
(TA10720); T. annulata endoplasmic reticulum
HSP90 (TA06470); and Bovine GRP94
associated with host endoplasmic reticulum
(anti‐mammalian GRP94). Track 1, total
detergent extract; track 2, eluate from beads
exposed to DMSO alone; track 3, eluate from
streptavidin beads pre‐bound with biotin‐GA
FIGURE 6 TA12105 (cytoplasmic HSP90) is
shown to be a functional ATPase. a. The
quality of purified full‐length recombinant
TA12015 was assessed following resolution
by 10% SDS polyacrylamide gel
electrophoresis and Coomassie Blue staining.
b. Immunoblotting and detection using the
antibody specific to TA12015 compared to an
antibody specific for bovine host HSP90. c.
Binding affinity of recombinant TA12015 for
ATP measured using a fluorescence quenching
ATP binding assay; the dissociation constant
(kd) was 178.6 μM. d. Analysis of Michaelis–
Menten kinetics by ɤ‐P32‐ATP hydrolysis
KINNAIRD ET AL. 7 of 13analysis (Figure 6b). The binding affinity of recombinant TA12015
for ATP was measured using a fluorescence quenching ATP binding
assay and the dissociation constant (Kd) calculated to be 178.6 μM.
It is known that the affinity of recombinant HSP90 for ATP and
ATPase activity is low in vitro and that in vivo, HSP90 activity is
highly regulated by the presence of a wide range of co‐factors such
as Aha1, CDC37, and p23 that alter the conformation (reviewed in
(Prodromou, 2012)). By using a ɤ‐P32‐ATP hydrolysis assay, a mea-
surable ATPase activity was obtained for recombinant TA12015 with
a Km of 490.1 μM indicating that TA12105 is a functional ATPase
(Figure 6d). When binding of HSP90 inhibitor 17‐AAG to recombi-
nant TA12105 was measured by a fluorescence quenching assay, a
Kd value of 7.67 μM was obtained (Figure 7a). Furthermore, the
ATPase activity of recombinant TA12105 could be inhibited by addi-
tion of 17‐AAG (Figure 7b) with an IC50 calculated as 20.59 μM.
These results indicate that the protein encoded by TA12105 has
functional properties similar to a classical HSP90 that can be blocked
by the inhibitor 17‐AAG.2.12 | HSP90 inhibitors differentially affect growth
of T. annulata‐infected leukocytes
Given that all three Theileria HSP90s tested were found to bind to GA
beads albeit to different extents, experiments were performed to
establish if there could be a differential effect of GA on uninfectedFIGURE 7 A. Hsp90 inhibitor 17‐AAG can
bind to and inhibit the ATPase activity of
recombinant TA12105. a. Recombinant
TA12105 binding to a classical HSP90
inhibitor, 17‐AAG in a fluorescence‐quenching
assay with a Kd of 7.67 μM. b. ATPase activity
of recombinant TA12105 inhibited by addition
of 17‐AAG in an ɤ‐P32‐ATP hydrolysis assay:
the IC50 for 17‐AAG was 20.59 μMBL20 cells compared to Theileria‐infected TBL20 cells. Cell number
and survival were monitored after 48 hr in the presence or absence
of drug. When compared to the control cultures exposed to the DMSO
vehicle only, BL20 cells were much more sensitive to GA at concentra-
tions that had significantly less effect on parasite‐infected TBL20
(Figure 8a). Thus, at 25 nM GA, 90% of TBL20 cells were viable com-
pared to only 49% in BL20 (P = 0.00285, BL20 vs TBL20); at 50 nM,
46% of TBL20 cells were viable but only 14% of BL20 (P = 0.00503,
BL20 vs TBL20). In contrast, at 100 nM GA, both BL20 and TBL20
were similarly sensitive to GA with only 10% and 9% respectively via-
ble cells, compared to control cultures (Figure 8a). The IC50 for BL20 is
24.5 nM and, for TBL20, 48.0 nM.
A similar experiment was carried out using 17‐AAG because the
effects of this derivative of geldanamycin could differ to those of GA,
particularly in vivo (Maroney et al., 2006). For 17‐AAG, an opposite
effect to that of GA was observed, as infected TBL20 cells were more
sensitive to the drug at 2.5 and 5 μM concentrations than uninfected
BL20 (Figure 8b). For BL20, 73% of cells remained viable in 2.5 μM
17‐AAG whereas for TBL20, only 41% were viable compared to the
DMSO control cultures (P = 0.06465). At 5 μM, while survival was poor
in both cell lines, TBL20 remained more sensitive (P = 0.04868). About
1 μM 17‐AAG had no significant effect on growth of either BL20 or
TBL20 compared to the respective DMSO control (P = 0.74517). For
TBL20, the IC50 was 2.3 μM compared to 3.4 μM for uninfected
BL20 cells.
FIGURE 8 Differential survival of Theileria infected relative to uninfected cells when treated with HSP90 inhibitors Geldanamycin and 17‐AAG.
Cultures were set up in triplicate at 1.4 × 105 ml−1. Geldanamycin and 17‐AAG added at 25, 50, and 100 nM for GA (a) and 1, 2.5, and 5 μM
for 17‐AAG (b); control cultures contained DMSO. Results are expressed as percent survival after drug treatment compared to control when
counted using Trypan Blue exclusion at 48 hr. Differences in survival between BL20 and TBL20 at 25 nM (P = 0.00285) and 50 nM GA
(P = 0.00503) were statistically significant (*) by Students t‐test whereas the slight difference observed at 100 nM GA was not (P = 0.547). For
17‐AAG, the detected decrease in survival for TBL20 compared to BL20 was borderline significant at 2.5 μM (P = 0.06465) and statistically
significant at 5 μM (**, P = 0.04868). Whereas at 1 μM 17‐AAG the marginal increase for TBL20 was not significant (P = 0.74517). Duplicate
experiments gave almost identical results in both cases
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Genes encoding HSP90 isoforms are conserved throughout the
Apicomplexa. It is likely that some or all perform functions that are
critical for cellular survival and show diversity relative to host isoforms;
thus, HSP90 may provide a target for rational design of novel
therapeutics against apicomplexan parasites. In addition, either host
or parasite HSP90 may play a key role in establishing or maintaining
the transformed phenotype of theT. annulata‐infected leukocyte. Four
T. annulata proteins encoded by genes belonging to the HSP90
family were aligned with orthologues from other closely related
apicomplexan parasites and a phylogenetic tree derived. Each of the
four isoforms clustered in one of four different orthologous groups,
indicative of a close relationship between the isoforms within the
Apicomplexa. However, whilst clearly related with conservation at
the amino acid level in certain key domains, such as the S/NKDEL
domain at the C‐terminus of endoplasmic reticulum forms, these
orthologues also showed regions of considerable divergence. For
example, the targeting domain of the otherwise related apicoplast
located isoforms showed significant divergence, which may reflect
species‐specific differences in mechanism, function, or client proteins
during the life cycles. Expression of RNA was constitutive for the three
HSP90 genes analyzed, as might be expected for proteins with critical
chaperone functions across multiple stages of the life cycle. However,
we did not detect full‐length TA06470 protein in piroplasms perhaps
suggestive of cellular processing. Alternatively, proteolytic cleavage
of this HSP90 isoform may occur during the piroplasm purification pro-
cedure from whole blood, where considerable variation can occur
between different preparations. Proteolytic cleavage may be the most
likely explanation to account for our observations as HSP90 cleavage
near to the N‐terminus has been reported to occur in leukaemic cell
lines during conditions of oxidative stress (Beck et al., 2012).By a combination of subcellular fractionation and IFAT, we con-
firmed localization of TA12105 to the macroschizont cytoplasm,
TA10720 to the apicoplast and TA06470 to be highly abundant and
very likely located in the parasite endoplasmic reticulum. TA06470
has a reasonably well‐conserved version (S/NDEL) of an ER retention
sequence (KDEL) at the C‐terminus (Munro & Pelham, 1987), a feature
in common with other HSP90s that have a chaperone function in the
ER. Subcellular fractionation studies indicated that small amounts of
TA06470 and/or TA10720 might be secreted into the host compart-
ment. There are two reasons for considering this to be possible; in Plas-
modium falciparum, HSP70 has been detected in the parasitophorous
vacuole (Grover, Chaubey, Ranade, & Tatu, 2013), and secondly, in
Theileria infected cells, the process that results in activation of tran-
scription factor NF‐κB does not appear to require bovine HSP90 nor
do IKK signalosome complexes recruited to the surface of the
macroschizont and involved in parasite‐dependent activation of NF‐κB
appear to contain detectable bovine HSP90 (Hermann & Dobbelaere,
2006). In the mammalian cell, IKK complexes typically contain HSP90
(Chen, Cao, & Goeddel, 2002) to facilitate appropriate protein confor-
mations, thus the following question arises: how does the Theileria‐
infected cell circumvent this fundamental requirement, and could it
involve a parasite derived HSP90 isoform? However, IFAT analysis to
co‐detect TA06470 and the macroschizont membrane surface protein,
TaSP, did not reveal any evidence of localization on the parasite sur-
face or outside in the host compartment, and a similar result was
obtained using anti‐TaSP together with anti‐TA10720 and TA12015
(data not shown). Thus, the formation of IKK signalosomes appears
to be independent of host or parasite HSP90, and the presence of a
significant amount of TA06470 in the cytoplasmic fraction is most
likely to be due to location in the macroschizont cytoplasm. Alterna-
tively, the ER within the macroschizont may be more fragile than that
of the host and be more easily subject to mechanical disruption during
KINNAIRD ET AL. 9 of 13extraction procedures, because host GRP94 was not detected in the
cytoplasmic fraction from either BL20 or TBL20 cells.
Mammalian GRP94 has been reported outside the ER and also in
small quantities on the cell surface (Altmeyer et al., 1996), particularly
in tumor cells (reviewed in (Marzec, Eletto, & Argon, 2012)) where it
is associated with stimulation of innate and adaptive anti‐tumor
immune responses (reviewed in (Luo and Lee, 2013)). In addition,
upregulation of GRP94 in cancer cells has been proposed to occur in
response to ER stress and is considered to be pro‐oncogenic and pro-
mote tumor cell migration (Zheng et al., 2008; Rachidi, Sun, & Li,
2015). Therefore, the observation that GRP94 detected by IFAT is sig-
nificantly upregulated in Theileria‐infected cells, with evidence (for the
ex‐vivo derived D7 cell line in particular) of sequestration at the periph-
ery of the host cell, may be functionally relevant (Figure 3). One possi-
ble reason for upregulation of GRP94 gene expression lies in the
extensive modification of gene expression that the macroschizont
stage of T. annulata imposes on the host cell (Kinnaird et al., 2013). This
includes upregulation of many genes encoding cellular proteins such as
exported MMPs, chemokines, signaling proteins, and transcription fac-
tors which presumably would demand a higher level of chaperoning
through the ER. Moreover, the recent link between GRP94 and trans-
port of filamentous actin and integrin to the cell periphery and regula-
tion of cellular migration may also be relevant (Ghosh et al., 2016).
Thus, it is possible that modulation of host GRP94 plays an important
role in promoting the phenotype of the transformed cell in terms of dis-
semination throughout and interaction with the host lymphoid system.
Both cytoplasmic forms of bovine and TheileriaHSP90 clearly bound
to GA‐beads with similar affinity. The slightly lower ratio of total protein
to eluted protein obtained for TA12105 compared to that for the bovine
host isoformmay indicate that the parasite protein has higher affinity for
GA as observed for the P. falciparum orthologue (Pallavi et al., 2010). In
contrast to TA12105, parasite ER HSP90, TA06470, and apicoplast
HSP90, TA10720 showed limited affinity for GA relative to the cytoplas-
mic form. Previous studies have demonstrated different sensitivities to
inhibitors between P. falciparum cytoplasmic HSP90 and mammalian
Hsp90 (Pallavi et al., 2010) using recombinant HSP90 and also when
expressed in yeast (Wider, Péli‐Gulli, Briand, Tatu, & Picard, 2009). Mam-
malian GRP94 has been reported to bind to GA (Immormino et al., 2009),
but using TBL20 extracts, we detected only a very small amount of bind-
ing to GA beads. This raises the possibility that GA affinity for or access
to GRP94 might be different between infected and uninfected cells.
Binding of the analogue inhibitor 17‐AAG was also demonstrated for
the parasite cytoplasmic HSP90 isoform, TA12105. Thus, it was consid-
ered likely that both GA and 17‐AGG could have a detrimental effect
on the growth and survival of Theileria infected leukocytes by targeting
and functionally inhibiting parasite and/or host HSP90 isoforms. There-
fore, it was of interest to determine whether such inhibition differed
between infected or uninfected cell lines.
Cell growth comparisons showed that BL20 cells were sensitive to
GA at concentrations that have no or little effect on TBL20 (25 and
50 nM). This differential sensitivity was not apparent at higher concen-
trations (100 nM) where viability was affected equally in both
uninfected and infected cells. One explanation for this is that the
increased levels of HSP90 isoforms that are available to bind GA in
TBL20 cells effectively titrate out the inhibitory molecule to levelswhere growth is less adversely affected. Alternatively, the known
increase in resistance to cell death of infected cells (Dobbelaere and
Kuenzi, 2004) may provide some protection against the outcome of
inhibition of HSP90 function at low levels of GA.
For 17‐AAG, the opposite effect was observed, as TBL20 cells
were more sensitive to the drug at 2.5 and 5 μM compared to BL20
cells. Recombinant TA12105 clearly had 17‐AAG binding capacity,
and it is possible that the other parasite isoforms also bind 17‐AAG.
Therefore, it is likely that one or more of these isoforms may be highly
sensitive to inhibition by 17‐AAG, and more so than for host isoforms.
As parasite HSP90s are likely to be essential for viability, TA10720 for
example, being required for optimal functioning of the apicoplast, inhi-
bition will kill the macroschizont and induce death of the host cell after
48 hr, a situation similar to that seen when TBL20 cells are treated
with buparvaquone (Guergnon, Dessauge, Langsley, & Garcia, 2003;
Kinnaird et al., 2013). Interestingly, the intracellular stage of Leishmania
was reported to exhibit greater sensitivity to 17‐AAG compared to
uninfected host cells (Petersen et al., 2012). Further detailed analysis
will be required to identify the Theileria isoform with greatest sensitiv-
ity to inhibition by 17‐AAG.
The finding that Theileria‐infected cells are sensitive to concentra-
tions of 17‐AAG that have limited effect on bovine host cells may pro-
vide a starting point for development of novel therapeutics. Such
studies are a necessary objective due to emerging field resistance to
buparvaquone (Mhadhbi et al., 2015). HSP90 inhibitors have been
demonstrated to modulate resistance to antifungal agents such as
fluconazole (Cowen & Lindquist, 2005) where high HSP90 is required
for azole resistance. This, combined with exploitation of structural
differences to specifically target parasite HSP90, may provide a
mechanism for dealing with emerging drug resistance, as suggested
for Plasmodium (Pavithra, Kumar, & Tatu, 2007; Shahinas, Folefoc, &
Pillai, 2013). Moreover, based on the degree of similarity across para-
site HSP90 isoforms within the ATP binding pocket, the likely 17‐
AGG binding site, design, and development of selective inhibitors of
Theileria HSP90 may provide information of relevance to the other
major vector borne Apicomplexa. Such compounds can be tested for
pathogen specificity with the convenient comparative cell culture sys-
tem utilized in this study.4 | EXPERIMENTAL PROCEDURES
4.1 | Parasite stocks and cell culture
All cells were cultured at 37°C in RPMI with 20% foetal calf serum as
described previously (Shiels et al., 1992). BL20 is an immortalized
bovine lymphosarcoma cell line (Morzaria, Roeder, Roberts, Chasey,
& Drew, 1982) routinely used as uninfected bovine cell control.
TBL20, parasite‐infected BL20, was previously obtained by in vitro
infection with T. annulata (strain Hissar) sporozoites (Shiels,
McDougall, Tait, & Brown, 1986) providing a system where infected
and non‐infected lines represent identical bovine genotypes. D7 is a
T. annulata‐infected cloned cell line derived by limiting dilution from
a mixed parasite genotype cell line TaA2 that differentiates efficiently
to merozoites when cultured in vitro at 41°C (Shiels et al., 1992).
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A published microarray dataset (Pieszko et al., 2015) was used to deter-
mine the expression profiles of T. annulata HSP90 isoforms across the
parasite life cycle, which included an in vitro parasite differentiation
time‐course. ArrayStar3 software (DNASTAR) was used to visualize and
analyze normalized gene expression values (log2). Protein sequences
for different parasite HSP90 isoforms were aligned using ClustalW2
(Larkin et al., 2007). The presence or absence of a signal peptide was
predicted using SignalP3.0 (Bendtsen, Nielsen, von Heijne, & Brunak,
2004), and apicoplast targeting was predicted using ApicoAP (Cilingir
& Broschat, 2015).
4.3 | Immunofluorescence assay and Western
blotting
For immunofluorescence analysis (IFAT), cytospin preparations of cells
were fixed in cold 3.7% p‐formaldehyde in phosphate buffered saline
(PBS) for 25 min, permeabilized in methanol for 10 min at −20°C then
probed with antibody following standard procedures (Schmuckli‐
Maurer et al., 2010). Western blotting was carried out using previously
described methodology (Kinnaird et al., 2013) with detection by chemi-
luminescence (SuperSignal West Pico Chemiluminescent Substrate,
Pierce). Semi‐quantitation of the X‐ray film signal was carried out using
an Alpha Innotec Fluorochem 5500 Imager and Spot Denso tool.
4.4 | Antibodies
In order to carry out further characterization and to differentiate
between host and parasite cytosolic Hsp90, a peptide sequence
located near the N‐terminus, KDPKQIEDQPDYYI that was unique to
TA12105, was selected. The alignment of the N‐terminal protein
sequences of bovine and T. annulata TA12105 protein sequences illus-
trates high sequence similarity, together with the divergent peptide
sequence that was used as the immunogen (Supplementary Figure 1).
BLAST of the bovine genome sequence indicated this peptide
sequence is not present in the host. Peptide synthesis, immunization,
and affinity purification were carried out by GenScript.
For TA06470, generation of protein for antisera production uti-
lized the C‐terminal portion from residue 824 to the end, expressed
as a GST fusion protein. The corresponding portion of the encoding
gene was cloned into the expression vector pGEX5x‐2 using EcoRI/
XhoI sites at the 5´ and at the 3´ ends, respectively. The primer
sequences used were as follows: forward, 5´‐ CGGAAT
TCTATTGTACAATGCAGCCAAGTTA‐3´ and reverse, 5´‐
CGCTCGAGCTATAATTCATCATTGGACCAA‐3´. For expression of
TA10720, the region of the encoding gene representing the C‐termi-
nus from residue 739 to the end was cloned into pGEX5x‐2 using
BamHI/ XhoI cloning sites. Primers were as follows: forward, 5´‐
CGGGATCCACGCACAACATCCAATAATAATCA‐3´ and reverse, 5´‐
AGGCTCGAGTTATACAAGGTCTAGGGTGTG‐3´. The template for
amplification was T. annulata piroplasm genomic DNA prepared from
cloned cell line C9 (Pain et al., 2005). Antiserum production was carried
out by the PTU/BS Unit at the Scottish National Blood Transfusion
Service, Pentlands Science Park Edinburgh.
Antisera were used at the following dilutions for both IFAT and
Western blot: TA12105, 1 in 1000 dilution; anti‐serum to TA10720and TA06470, both at 1500 dilution. Commercial anti‐sera against
mammalian GRP94 (Sigma Aldrich, G4545) was used at 1 in 500 dilu-
tion for IFAT and 1 in 2000 dilution for Western analysis, and antise-
rum against the cytoplasmic form of mammalian HSP90 (Enzo
LifeSciences SPS771) was used at 1 in 1000 dilution in Western blot-
ting. A monoclonal antibody (5E1) that recognizes a major T. annulata
merozoite/piroplasm 30 kDa surface antigen (Glascodine et al., 1990)
was used at a 1 in 10 dilution of culture supernatant. A polyclonal anti-
body that recognizes a macroschizont surface protein, anti‐TaSP
(Schnittger et al., 2002), was used at 1 in 1000 dilution for immunoflu-
orescence. Purified recombinant TA12105 was detected by Western
blotting using an anti‐6× His antibody (Invitrogen).4.5 | Cell fractionation
Cells pellets of 5 × 106 cells were washed in PBS then subjected to a
sequential extraction procedure using a Subcellular Proteome Extrac-
tion kit (S‐PEK; Calbiochem) to enrich for components from the follow-
ing cellular compartments: cytoplasm, membranes and organelles,
nucleus and finally insoluble cytoskeletal proteins such as intermediate
filaments. If necessary, 200 μl aliquots were concentrated for gel
analysis using a protein precipitation reagent (Calbiochem).4.6 | Production of recombinant TA12105 and
estimation of binding affinity and activity
Full‐length TA12105 was PCR amplified using forward primer
sequence 5´‐GCCGCGGGATCCATGGCATCAAAGGAAGAGACACC
and reverse primer 5´‐ GCGGCGGGTACCTCAGTCAACTTCCTCC
ATTTTGGAG. These included BamHI and KpnI sites respectively for
cloning the 2.7 kb PCR product into the expression vector pRSET A
(Invitrogen). This added an additional 35 amino acids consisting of a
6× His tag and an Xpress™ epitope to the N‐terminus of the protein
product. The recombinant protein was expressed in E. coli BL21 pLysS
cells. Immunoblotting and detection with an antibody specific to the
histidine tag confirmed a polypeptide of the predicted size for
recombinant TA12105 which was then affinity purified on Ni‐NTA
beads (Qiagen). Purity was assessed by 10% SDS‐polyacrylamide gel
electrophoresis and Coomassie Blue staining.
The binding affinity of recombinant TA12015 for ATP and 17‐
AAG was measured using a fluorescence quenching binding assay as
previously described (Pallavi et al., 2010). Briefly, the assay buffer for
ATP binding was 40 mM Tris–HCl pH 7.5, 100 mM KCl, 5 mM MgCl2,
10 mM DTT with 50 μg purified His tagged TA12105. Intrinsic trypto-
phan fluorescence was measured by scanning the emission spectrum
in the wavelength range of 300–400 nM using an excitation wave-
length of 280 nM. The maximum wavelength (λ max) for intrinsic fluo-
rescence was observed to be 340 nM. Change in intrinsic fluorescence
in the presence of ligands was plotted against ligand concentration to
calculate dissociation constants. Data were analyzed using GraphPad®
Prism 5 statistical software.
ATPase activity of recombinant His‐tagged TA12015 was ana-
lyzed as carried out previously (Singh, Shah, & Tatu, 2014) by measur-
ing ATP hydrolysis rate with ɤ‐P32‐ATP as a tracer. The concentration
of cold ATP ranged from 50 to 4000 μM. As a control, 17‐AAG was
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specific background ATPase activity. This value was subtracted from
the total activity and the remaining activity used to determine ATP
hydrolysis rate. Data analysis utilized GraphPad® Prism 5 and
Michaelis–Menten kinetics. The ATPase inhibition assay was carried
out using the same methodology with a fixed concentration of ATP
(2 mM) and a range of different 17‐AAG concentrations (2.5 to
50 μM). Percent residual ATPase activity was plotted against log
17‐AAG concentration to determine the IC50.
4.7 | Geldanamycin affinity
Cell extracts were prepared largely according to (Moulick et al., 2011).
Briefly, protein extracts were prepared from 3 to 4 × 107 cells in a lysis
buffer containing 20 mM Hepes (pH 7.4), 5 mM MgCl2, 50 mM KCl,
0.01% NP‐40, and protein inhibitor cocktail, freeze thawed three times
then gently sonicated to shear DNA. Extracts were centrifuged at
14,000 RPM for 10 min and the supernatants used in the GA binding
assay. Typically, the protein concentrations of the extracts were
10 mg/ml, and 750 μg were used in a binding assay. Binding of
HSP90 from cells extracts was carried out using biotinylated
geldanamycin (InvivoGen), pre‐bound to streptavidin magnetic beads
(Dynabeads® MyOne™ Streptavidin T1, Invitrogen). Binding of
biotinylated GA to Streptavidin magnetic beads was carried out
according to the manufacturer's protocol except that biotinylated GA
was solubilised in DMSO and incubated with beads that had been
washed in lysis buffer, in the ratio 5 nmol GA to 100 μl beads.
Dynabeads exposed to DMSO alone were used as a negative control.
4.8 | HSP90 inhibitor treatment of cell cultures
Foreachcondition, cultureswere setup in triplicate at1.4×105 cells/ml.
Geldanamycin and 17‐AAG (InvivoGen) were solubilised in DMSO and
added to cultures at the concentrations detailed in Results with DMSO
used as control. Data were expressed as percent survival after drug
treatment compared to the respective DMSO control when counted at
48 hr, using Trypan Blue exclusion to assess cell viability and a
haemocytometer.
4.9 | Sequence analysis
Amino acid sequences representing HSP90 isoforms were downloaded
from theNCBI database for a number of Apicomplexan species including
Theileria parva, Theileria orientalis, Babesia bovis, Babesia bigemina,
Babesia equi, Plasmodium falciparum, Plasmodium vivax, Plasmodium
chabaudi, Toxoplasma gondii, and Cryptosporidium parvum. The accession
numbers for these sequences are detailed in Supplementary Table 1B. A
maximum likelihood phylogenetic tree was constructed using RAxML
(Stamatakis, 2014), and bootstrapping was performed to assessed tree
stability using 100 iterations. The resulting bipartitions tree was visual-
ized using FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
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